Birdwatch Note Rating
2024-03-13 06:27:01 UTC - HELPFUL
Rated by Participant: 7EDF0C871520BC30F46867F349FB8D78C0705C406CCFAF579B715AF01AFEA499
Participant Details
Original Note:
No, the Ebola clinical trial involving the COVID-19 drug Remdesivir did not show Remdesivir had a 53% mortality rate. This is a false interpretation of the study. The study showed that Ebola infection had a 53% mortality rate. Ebola can have up to a 90% mortality rate https://www.nejm.org/doi/full/10.1056/nejmoa1910993 https://www.paho.org/en/topics/ebola-virus-disease
All Note Details